DOUG HASTINGS is a nationally recognized health care transaction lawyer and advisor on health system change. For more than 30 years, Mr. Hastings and his colleagues at Epstein Becker Green have designed, implemented, and successfully closed scores of complex health care transactions on behalf of hospitals, health systems, academic medical centers, post-acute providers, large medical groups, and health plans. Described in Chambers USA as a "visionary" and "transactional genius," he advises clients on the strategic considerations, corporate architecture, and regulatory compliance components of proposed health care transactions, including the payment and delivery reform, governance, antitrust, exempt tax, and fraud and abuse implications.
Since 2001, he has been closely involved at the national level with efforts to improve the quality and cost efficiency of the U.S. health care system, and is known for his role in the launch of accountable care organizations and population health initiatives in both the public and private sectors.
Mr. Hastings served on the Board on Health Care Services of the Institute of Medicine (IOM) from 2003 to 2011 and on the IOM's Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care from 2010 to 2013. He is a Past President and Fellow of the American Health Lawyers Association. Named in 2006 as the first Chair of the Board of Directors of Epstein Becker Green, Mr. Hastings served in that role until January 1, 2014.
Articles in the National Law Review database by Douglas A. Hastings